Park Square Financial Group, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Park Square Financial Group, LLC
- $145 Billion
- Q4 2024
A detailed history of Park Square Financial Group, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Park Square Financial Group, LLC holds 121 shares of ALNY stock, worth $29,856. This represents 0.02% of its overall portfolio holdings.
Number of Shares
121Holding current value
$29,856% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
670Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.1 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.14 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.36 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.72 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.08 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.4B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...